These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7279810)

  • 1. Interference with in vivo growth and metastasis of prostate adenocarcinoma (PA-III) by ICRF-159.
    Pollard M; Burleson GR; Luckert PH
    Prostate; 1981; 2(1):1-9. PubMed ID: 7279810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of high dose diethylstilbestrol and ICRF-159 on the growth and metastases of the R3327 MAT-LyLu prostate-derived tumor.
    Heston WD; Kadmon D; Fair WR
    Cancer Lett; 1981 Jul; 13(2):139-45. PubMed ID: 7306951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of melphalan, ICRF-159, and hydroxyurea in metastatic prostate cancer: a preliminary report.
    Kvols LK; Eagan RT; Myers RP
    Cancer Treat Rep; 1977; 61(2):311-2. PubMed ID: 326400
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of surgery and adjuvant chemotherapy on the R3327 MAT-Ly Lu tumor.
    Kadmon D; Heston WD; Fair WR
    Prostate; 1981; 2(3):299-307. PubMed ID: 7301657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of ICRF 159 and trition WR 1339 on metastases of a rat epithelioma.
    Pimm MV; Baldwin RW
    Br J Cancer; 1975 Jan; 31(1):62-7. PubMed ID: 1156509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The inhibitory effect of 4-hydroxyphenyl retinamide (4-HPR) on metastasis of prostate adenocarcinoma-III cells in Lobund-Wistar rats.
    Pollard M; Luckert PH
    Cancer Lett; 1991 Aug; 59(2):159-63. PubMed ID: 1832081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereoselective effects of cis- and trans-cyclopropylbis (dioxopiperazines) related to ICRF-159 on metastases of hamster lung adenocarcinoma.
    Witiak DT; Lee HJ; Goldman HD; Zwilling BS
    J Med Chem; 1978 Dec; 21(12):1194-7. PubMed ID: 722727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ICRF-159 (razoxane) in patients with advanced adenocarcinoma of the endometrium. A Gynecologic Oncology Group Study.
    Homesley HD; Blessing JA; Conroy J; Hatch K; DiSaia PJ; Twiggs LB
    Am J Clin Oncol; 1986 Feb; 9(1):15-7. PubMed ID: 3953488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thalidomide promotes metastasis of prostate adenocarcinoma cells (PA-III) in L-W rats.
    Pollard M
    Cancer Lett; 1996 Mar; 101(1):21-4. PubMed ID: 8625277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of spontaneous metastasis manifested by three rat prostate adenocarcinomas.
    Pollard M; Luckert PH
    J Surg Oncol; 1979 Dec; 12(4):371-7. PubMed ID: 522491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimetastatic effects of razoxane in a rat osteosarcoma model.
    Wingen F; Spring H; Schmähl D
    Clin Exp Metastasis; 1987; 5(1):9-16. PubMed ID: 3470164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ICRF-159 (razoxane) in patients with advanced nonsquamous cell carcinoma of the cervix. A Gynecologic Oncology Group study.
    Homesley HD; Blessing JA; Berman M
    Am J Clin Oncol; 1986 Aug; 9(4):325-6. PubMed ID: 3751970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of experimental colorectal cancer by razoxane (ICRF-159).
    Gilbert JM; Thompson EM; Slavin G; Kark AE
    Br J Surg; 1984 Aug; 71(8):600-3. PubMed ID: 6743979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I-II evaluation of razoxane (ICRF-159) and doxorubicin in gastrointestinal cancer. A Southeastern Cancer Study Group Trial.
    DeSimone PA; Greco FA; Omura GA; Bartolucci A
    Am J Clin Oncol; 1986 Jun; 9(3):185-6. PubMed ID: 3728369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the R3327MAT-Lu prostatic tumor by diethylstilbestrol and 1,2-bis(3,5-dioxopiperazin-1-yl)propane.
    Lazan DW; Heston WD; Kadmon D; Fair WR
    Cancer Res; 1982 Apr; 42(4):1390-4. PubMed ID: 7060012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase III study of ICRF-159 versus 5-FU in the treatment of advanced metastatic colorectal carcinoma.
    Paul AR; Catalano RB; Engstrom PF
    Cancer Treat Rep; 1980; 64(10-11):1047-9. PubMed ID: 7006805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of (+/-) 1,2-bis(3,5-dioxopiperazin-1-yl) propane (ICRF 159) on liver metastases from a hamster lymphoma.
    Atherton A
    Eur J Cancer (1965); 1975 Jun; 11(6):383-8. PubMed ID: 1174351
    [No Abstract]   [Full Text] [Related]  

  • 18. Combination of radiation and razoxane (ICRF 159) in vivo.
    Hellmann K; Grimshaw MB; Hutchinson GE
    Int J Radiat Oncol Biol Phys; 1978; 4(1-2):109-13. PubMed ID: 632139
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of stereoisomers related to ICRF-159 on metastasis of B16 melanoma.
    Zwilling BS; Campolito LB; Reiches NA; George T; Witiak DT
    Br J Cancer; 1981 Oct; 44(4):578-83. PubMed ID: 7295515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The selective estrogen receptor modulator trioxifene (LY133314) inhibits metastasis and extends survival in the PAIII rat prostatic carcinoma model.
    Neubauer BL; McNulty AM; Chedid M; Chen K; Goode RL; Johnson MA; Jones CD; Krishnan V; Lynch R; Osborne HE; Graff JR
    Cancer Res; 2003 Sep; 63(18):6056-62. PubMed ID: 14522935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.